This paper describes a novel combined approach to targeting GBM with multiple RNA-based therapeutics. Overall, the results demonstrate the good potential of a smart safe and clinically applicable combined regimen for the treatment of glioblastoma, opening up a new avenue in the treatment of this aggressive disease.
Aptamer-based RNA-bio-drugs for the combined therapy of GBM
Condorelli G.;De Franciscis V.;Catuogno S.;Esposito C. L.
2022
Abstract
This paper describes a novel combined approach to targeting GBM with multiple RNA-based therapeutics. Overall, the results demonstrate the good potential of a smart safe and clinically applicable combined regimen for the treatment of glioblastoma, opening up a new avenue in the treatment of this aggressive disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
